Sunday, August 30, 2015
INDIAN EQUITY MARKET OUTLOOK-31 Aug 2015
INDIAN BENCHMARKS are likely to start the session on a negative note as the global cues look unsupportive with SGX Nifty trading 42.00 points higher.
Headlines for the day:
Aurobindo Pharma receives USFDA approval for Raloxifene Hydrochloride
Bharti Airtel & Idea Hike Post-paid Data Tariffs By 20% In Delhi
ONGC, partners including OIL to invest $24 billion in Mozambique gas field
Trend in FII flows: The FIIs were net buyers of Rs 56.41 Cr in the cash segment on Friday while the DIIs were net buyers of Rs 847.43 Cr, as per the provisional figures released by the NSE.
Benchmark Treasury yields dipped to 2.04% with Australian bonds tracking the overnight gain in US debt. Asian stock markets retreated...
In the broader market, the BSE Midcap index was trading 108 points higher at 15,587 levels, while the BSE Smallcap index was trading at 15,...
INDIAN BENCHMARKS: SENSEX DOWN 51 POINTS, NIFTY 50 AT 8918 The market snapped two-day winning streak as profit booking drove equit...
The Indian market is likely to swing to global macro data and June quarter earnings of few public sector companies next week. Mond...